IL-31: A new key player in dermatology and beyond

被引：112

作者：

Bagci, Isin Sinem ^{[1
]}

Ruzicka, Thomas ^{[1
]}

机构：

[1] Ludwig Maximilians Univ Munchen, Dept Dermatol & Allergol, Frauenlobstr 9-11, D-80337 Munich, Germany

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2018年 / 141卷 / 03期

关键词：

IL-31; receptors; interleukins; cytokines; pruritus; atopic eczema; ONCOSTATIN-M RECEPTOR; CHRONIC SPONTANEOUS URTICARIA; CLIENT-OWNED DOGS; ATOPIC-DERMATITIS; SERUM IL-31; SIGNAL-TRANSDUCTION; INTERLEUKIN; 31; T-CELLS; LOKIVETMAB ZTS-00103289; MONOCLONAL-ANTIBODY;

D O I：

10.1016/j.jaci.2017.10.045

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

IL-31 is a novel cytokine expressed in many human tissues and involved mainly in T(H)2-weighted inflammation. IL-31 signals through a receptor complex consisting of IL-31 receptor a and oncostatin M receptor b. The available data show that IL-31 is strongly linked with chronic pruritic skin disorders, such as atopic eczema, and represents a novel target for directed drug therapy. Regulation of immune responses and cellular differentiation and proliferation are recently elucidated effects of IL-31, suggesting a more complex and diverse area of effect for this novel cytokine. This review summarizes the current knowledge on IL-31 and its receptors and the involvement of IL-31 in diseases both in human subjects and mouse models.

引用

页码：858 / 866

页数：9

共 50 条

[21] Cytokine transcriptome profiling in acute experimental canine atopic dermatitis skin lesions after IL-31 inhibition with lokivetmab
Tamamoto-Mochizuki, Chie
Crawford, Natalie
Eder, Jordan M.
Gonzales, Andrea J.
Olivry, Thierry
VETERINARY DERMATOLOGY, 2023, : 327 - 338
[22] IL-33/IL-31 Axis: A Potential Inflammatory Pathway
Di Salvo, Eleonora
Ventura-Spagnolo, Elvira
Casciaro, Marco
Navarra, Michele
Gangemi, Sebastiano
MEDIATORS OF INFLAMMATION, 2018, 2018
[23] The role of IL-17, IL-23 and IL-31, IL-33 in allergic skin diseases
Topal, Fatih A.
Zuberbier, Torsten
Makris, Michael P.
Hofmann, Maja
CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 20 (04) : 367 - 373
[24] Repeated administration of IL-31 upregulates IL-31 receptor A (IL-31RA) in dorsal root ganglia and causes severe itch-associated scratching behaviour in mice
Arai, Iwao
Tsuji, Minoru
Miyagawa, Kazuya
Takeda, Hiroshi
Akiyama, Nobutake
Saito, Saburo
EXPERIMENTAL DERMATOLOGY, 2015, 24 (01) : 75 - 78
[25] IL-33/IL-31 Axis: A New Pathological Mechanism for EGFR Tyrosine Kinase Inhibitors-Associated Skin Toxicity?
Gangemi, Sebastiano
Franchina, Tindara
Minciullo, Paola Lucia
Profita, Mirella
Zanghi, Mariangela
David, Antonio
Kennez, Ivanna
Adamo, Vincenzo
JOURNAL OF CELLULAR BIOCHEMISTRY, 2013, 114 (12) : 2673 - 2676
[26] IL-31 induces antitumor immunity in breast carcinoma
Kan, Tal
Feldman, Erik
Timaner, Michael
Raviv, Ziv
Shen-Orr, Shai
Aronheim, Ami
Shaked, Yuval
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
[27] IL-31 Serum Protein and Tissue rnRNA Levels in Patients with Atopic Dermatitis
Kim, Song
Kim, Hyun-Je
Yang, Hee Seung
Kim, Eugene
Huh, Ik-Soo
Yang, Jun-Mo
ANNALS OF DERMATOLOGY, 2011, 23 (04) : 468 - 473
[28] Increased levels of interleukin 31 (IL-31) in osteoporosis
Ginaldi, Lia
De Martinis, Massimo
Ciccarelli, Fedra
Saitta, Salvatore
Imbesi, Selene
Mannucci, Carmen
Gangemi, Sebastiano
BMC IMMUNOLOGY, 2015, 16
[29] Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis
Kato, Atsuhiko
Fujii, Etsuko
Watanabe, Takeshi
Takashima, Yoshiaki
Matsushita, Hiroaki
Furuhashi, Takuya
Morita, Akimichi
JOURNAL OF DERMATOLOGICAL SCIENCE, 2014, 74 (03) : 229 - 235
[30] Biologics for Itch: IL-4/IL-13, IL-31, IL-17, and IL-23 Antagonists
Reich A.
Szczęch J.
Samotij D.
Current Dermatology Reports, 2017, 6 (4) : 263 - 272

← 1 2 3 4 5 →